Brief: SK Bioscience Signs Supply Contracts Worth $172 Million With Novavax
23/12/2021 23:05
Dec 24 (Reuters) -
* SK BIOSCIENCE: SIGNS SUPPLY CONTRACTS WORTH $172 MILLION
WITH
NOVAVAX
Source text for Eikon: https://bit.ly/30VHDG7,
https://bit.ly/3stjNgf
Further company coverage: 302440.KS
((Heekyong.Yang@thomsonreuters.com;))
Recent news on SK Bioscience Co
See all newsBrief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine